Glasgow Royal Infirmary Pharmacy Department PHARMACEUTICAL ASPECTS OF INTRAVENOUS DRUG ADMINISTRATION.

Slides:



Advertisements
Similar presentations
Prescribing IV Infusions
Advertisements

Oxford University Hospitals NHS Trust Injectable medicines study day:
Pharmaceutical aspects of Iv medications
Complications of IV drug Therapy March Site of administration Benefits?Complications?
Mathematical Aspects of Intravenous Therapy
Intravenous Drug Administration
Clinical Calculation 5th Edition
IV Drug Administration
What is an IV push medication?
Lecture 4.
Epilepsy 2 Dr. Hawar A. Mykhan.
Introduction:  The preparation of parenteral admixture usually involves the addition of one or more drugs to large volume solutions such as intravenous.
Reconstituting Powdered Medications
Fundamental Nursing Chapter 35 Intravenous Medications
Intravenous infusions, Parenteral admixtures, and rate of flow calculations Dr. Osama A. A. Ahmed.
Pharmacokinetics Questions
Introduction to Prescribing - Part 2 3 rd year Medical Students.
Calculating Drug Dosages
Chapter 9 Calculating Drug Dosages Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1.
Routes of Drug Administration
Laplace transformation
Practical Pharmacokinetics
Paediatric Prescribing and Common Medications Diana Mowbray Paediatric Clinical Pharmacist Rotherham NHS Foundation Trust.
434 PHT Sterile Dosage Forms Nahla S. Barakat, Ph
McGraw-Hill ©2010 by the McGraw-Hill Companies, Inc All Rights Reserved Math for the Pharmacy Technician: Concepts and Calculations Chapter 8: Intravenous.
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Parenteral products are dosage forms, which are delivered to the patient by a injection or implantation through the skin or other-external layers such.
Pharmacology Department
Injectable Solutions Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
INJECTABLES Nora A. Alkhudair. Injections Percutaneous introduction of a medicinal substance, fluid or nutrient into the body. (e. g. intradermal, subcutaneous,
Preparation & Administration of Ipilimumab
ACLS Workshop DCH Regional Medical Center and Harrison School of Pharmacy, Auburn University.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
Bioavailability Dr Mohammad Issa.
Pharmacology Department
Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences.
Hyper CVAD (First Arm) DaysDoseDrug Days 1, 2, and 3300mg/m 2 IV over 3 hours Q12H x 6 doses Cyclophosphamide Day 450mg/ m 2 IV Doxorubicin Days 4 and.
Introduction The following procedure is for the reconstitution of aldoxorubicin drug product for use in the ALDOXORUBICIN-P3-STS-01 study. The reconstitution.
Pharmacology I BMS 242 Lecture I (Continued) Introduction; Scope of Pharmacology Routes of Drug Administration Dr. Aya M. Serry 2015/2016.
Common Venipuncture Sites Dose Calculators Insertion of Peripheral IV Catheter Insertion of a Central Line Catheter Methods of IV Medication Administrations.
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
Pharmaceutics I صيدلانيات 1 Unit 2 Route of Drug Administration
Concentrations of Drug Products Concentrations are expressions of the strength of drugs in aqueous solutions or suspensions Concentrations of drugs in.
Drug Dosages and Intravenous Calculations
Copyright © 2015 Cengage Learning® Chapter 9 Parenteral Medication Labels and Dosage Calculation.
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Standard Operating Procedure for the Preparation and Administration of Injectable medicines in Clinical Areas Prescription, preparation and administration.
 1-What is the best drug to be used?  2-How it is going to be given?
Clinical Pharmacokinetic Equations and Calculations
Copyright © 2015 Cengage Learning® Chapter 9 Parenteral Medication Labels and Dosage Calculation.
Danielle DelVillano, Pharm.D.
IV Push. Direct Injection, Bolus, IVP Administration of a drug directly into the venous access device through the proximal injection port on a continuous.
Practice Problems Biopharmaceutics-I.
Rate Of Flow DeAna Smalls PBP Program August 3, 2016.
RECONSTITUTION, STABILITY AND STERILITY OF INJECTABLE DRUGS Presenter: Deus D. Sinibagiye (Pharmacist) PHARMACY DEPARTMENT.
RECONSTITUTION, STABILITY AND STERILITY OF INJECTABLE DRUGS
3 Aseptic Calculations.
Key Features of the UCLHguide
15 Introduction to Sterile Products.
Parenteral Dosage of Drugs
Presentation On Routes of drug administration & it’s significance
Chemical and Physical Compatibility of Continuous Intravenous Drug Infusion Combinations used in Paediatric Intensive Care Andy Fox and Marisa van der.
Introduction; Scope of Pharmacology Routes of Drug Administration
Fundamental Nursing Chapter 35 Intravenous Medications
Medical Dosage Calculations A Dimensional Analysis Approach
Fundamental Nursing Chapter 35 Intravenous Medications
Chapter 5 Calculations for Sterile Compounding.
Presentation transcript:

Glasgow Royal Infirmary Pharmacy Department PHARMACEUTICAL ASPECTS OF INTRAVENOUS DRUG ADMINISTRATION

Differences IV  ORAL route IV administration leads to: Higher peak concentrations Greater total quantity of drug absorbed Avoids 1 st pass metabolism However requires more training, knowledge, skills and precautions time Conc.

IV route - Advantages Emergency situations / immediate response e.g. adrenaline in cardiac arrest. Loading dose e.g.digoxin, phenytoin Patient unable to swallow or tolerate other routes Sustained drug levels required Drug cannot be given by another route because of its chemical property e.g. cytotoxics, cefotaxime

Less painful than I.M. injection. Administration can be stopped quickly Allows dosing of unconscious, uncooperative and uncontrollable patients. To achieve effects unattainable by oral administration.

IV route - Disadvantages  Risk of toxicity Risk of embolism Risk of extravasation/phlebitis Fluid overload Problems with compatibility + stability Risk of microbial contamination Increased cost More training required

BOLUS 3-10 minutes Quick/easy/economical Tendency to administer too quickly causing damage to veins. Sudden anaphylactic reactions Only limited volumes can be administered

Intermittent IV INFUSION minutes One-off or repeated doses E.g. Gentamicin, vancomycin, erythromycin High plasma concentration achieved rapidly over longer periods.

Continuous IV INFUSION Delivers constant level of drug Used for drugs with a rapid elimination rate or a very short half-life e.g. midazolam BUT Fluid overload, incompatibility, contamination, incomplete mixing, phlebitis and rate calculations can be problematic.

Formulation of I.V. drugs Reconstitution required -Dry powder e.g. amoxicillin -Allows prolonged storage BUT - Is time consuming - Risk of contamination, foaming, glass particles, pressurised vials.

Solutions needing further dilution e.g. Ranitidine, Amiodarone No reconstitution necessary BUT Time consuming Prone to vacuum/pressure problems Can cause glass breakage Risk of microbial contamination.

‘Ready to use’ No further dilution needed Come in bags/small volume amps/syringes e.g. metoclopramide, adenosine, morphine PCAs Easy to use & time saving Minimal microbial contamination BUT Microbial contamination Fluid overload

Factors influencing Stability & compatibility A proportion of the drug will be lost between time of preparation and entry into the bloodstream by degradation, precipitation or an interaction.

Degradation By hydrolysis in aqueous solution May be accelerated by pH change Minimised by using reccomended diluent

Photodegradation Breakdown by light. e.g. Vitamin A, sodium nitroprusside, liposomal amphotericin. May not be clinically important provided direct exposure to strong daylight is avoided e.g. furosemide.

Precipitation Precipitates are inactive but harmful: can block catheters, damage capillaries and cause emboli. May be transparent or pale Affected by differences in pH Anions and cations mix to form ion pairs Most drugs are more soluble as temp. increases

Blinding of drugs to plastics Most equipment made from plastic Drug binding difficult to predict as it depends on: Conc. Flow rate, vehicle, surface area, temp. pH and time. Care with insulin, diazepam, nitrates....

Leaching of plasticisers Oils and surfactants contained in PVC bags can leak out and affect compatibility and stability of drugs. e.g. Ciclosporin infusion must be used within 6 hours as polyethoxylated castor oil in the solution causes phthalate to leach from PVC.

Summary Add one drug at a time following manufacturers advice Mix thoroughly to avoid layering Examine solution regularly Add most concentrated or most soluble additive first Strongly coloured solutions will hide reactions Observe patient for ADR’s

Intravenous Antibiotics State for each of the following: Diluent & volume required for reconstitution Volume required for dose Type of injection Gentamicin 260mgErythromycin 750mg Co-amoxiclav 1.2gMetronidazole 500mg Tazocin 4.5g

Example (1) How would you prepare and administer Flucloxacillin 1g IV? Each 1g vial should be reconstituted with 20ml WFI (SPC) Add 20ml reconstituted solution to 100ml NaCl 0.9% or glucose 5% (BNF) Can be given as an infusion over 30-60min. or bolus injection over 3-4 min. (BNF & SPC)

Example (2) How would you prepare & administer Vancomycin 1250mg Each 500mg vial should be reconstituted with 10ml WFI – Use 3 vials (BNF Appendix 6) Got 1500mg  30ml 1250mg  1250 x 30 / 1500 = 25ml Conc. of infusion fluid must be ≤ 5mg/ml (BNF) Therefore put 25ml into 250ml of Nacl 0.9% or Glucose 5% Must be given as an infusion (SPC & BNF)

References to use BNF appendix 6 BNF monographs SPC ( Technical leaflet JHO handbook Medusa I.V. drugs guidance manual ( Ward clinical pharmacist Medicines information (ext 24407)

How would you prepare and administer: Gentamicin 260mg Co-amoxiclav 1.2g Tazocin 4.5g Erythromycin 750mg Metronidazole 500mg

Answers Gentamicin 260mg 4 x 80mg/2ml vials. Withdraw 6.5ml and add to 100ml NaCl 0.9% or Glucose 5%. Give over min. Co-amoxiclav 1.2g 1.2g vial reconstituted with 20ml WFI. Bolus (3-4min.) or infusion in ml NaCl0.9% given over 30-40min.

Answers (cont) Tazocin 4.5g vial reconstituted with 20ml WFI or NaCl 0.9%. Bolus (3-5min.) or infusion in 100ml NaCl 0.9% over 20-30min. Erythromycin 750mg 1000mg vial reconstituted with 20ml WFI. Withdraw 15ml (750mg) and add to 250ml NaCl 0.9%. (Cannot get 150ml bag!!) Infuse over 60min.

Answers (cont.) Metronidazole 500mg 100ml bag 5mg/ml = 500mg. Infuse over 20 min.